Genetic Variants in Genes Related to Lung Function and Interstitial Lung Diseases Are Associated with Worse Outcomes in Severe COVID-19 and Lung Performance in the Post-COVID-19 Condition
International Journal of Molecular Sciences · 26.02.2025 · 26 (5) · 2046
DOI: 10.3390/ijms26052046 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2025. Verfasst von Ingrid Fricke-Galindo und 16 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: COVID-19, Lung Diseases, Interstitial, Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas (INER).
Abstract (Originalsprache)
Genetic variants related to susceptibility to chronic respiratory conditions such as interstitial lung disease (ILD) could share critical pathways in the pathogenesis of COVID-19 and be implicated in COVID-19 outcomes and post-COVID-19. We aimed to identify the participation of genetic variants in lung function and ILD genes in severe COVID-19 outcomes and post-COVID-19 condition. We studied 936 hospitalized patients with COVID-19. The requirement of invasive mechanical ventilation (IMV) and the acute respiratory distress syndrome (ARDS) classification were considered. The mortality was assessed as the in-hospital death. The post-COVID-19 group included 102 patients evaluated for pulmonary function tests four times during the year after discharge. Five variants (FAM13A rs2609255, DSP rs2076295, TOLLIP rs111521887, TERT rs2736100, and THSD4 rs872471) were genotyped using TaqMan assays. A multifactor dimensionality reduction method (MDR) was performed for epistasis estimation. The TERT rs2736100 and THSD4 rs872471 variants were associated with differential risk for ARDS severity (moderate vs. severe, CC + CA, p = 0.044, OR = 0.66, 95% CI = 0.44–0.99; and GG p = 0.034, OR = 2.22, 95% CI = 1.04–4.72, respectively). These variants and FAM13A rs2609255 were also related to pulmonary function post-COVID-19. The MDR analysis showed differential epistasis and correlation of the genetic variants included in this study. The well-known variants in recognized genes related to pulmonary function worsening and interstitial disorders are related to the severity and mortality of COVID-19 and lung performance in the post-COVID-19 condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
- Laboratorio Clínico, Centro Especializado de Atención a Personas con Discapacidad Visual, Instituto de Salud del Estado de México, Naucalpan 53000, Mexico State, Mexico.
- Facultad de Medicina Benemérita, Universidad Autónoma de Puebla, Puebla de Zaragoza 72420, Puebla, Mexico.
- Instituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez 32310, Chihuahua, Mexico.
ORCID-Profile: Ingrid Fricke-Galindo, Salvador García-Carmona, Brandon Bautista-Becerril, Gloria Pérez-Rubio, Ivette Buendia-Roldan, Leslie Chávez-Galán, Karol J Nava-Quiroz, Jesús Alanis-Ponce, Jessica I Erives-Sedano, Yashohara Méndez-Velasco, Grecia E Osuna-Espinoza, Rubén Segura-Castañeda, Uriel N Solano-Candia, Ramcés Falfán-Valencia
Förderung
- Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas (INER)
Zitieren
APA
Fricke-Galindo, I., García-Carmona, S., Bautista-Becerril, B., Pérez-Rubio, G., Buendia-Roldan, I., Chávez-Galán, L., Nava-Quiroz, K. J., Alanis-Ponce, J., Reséndiz-Hernández, J. M., Blanco-Aguilar, E., Erives-Sedano, J. I., Méndez-Velasco, Y., Osuna-Espinoza, G. E., Salvador-Hernández, F., Segura-Castañeda, R., Solano-Candia, U. N., & Falfán-Valencia, R. (2025). Genetic Variants in Genes Related to Lung Function and Interstitial Lung Diseases Are Associated with Worse Outcomes in Severe COVID-19 and Lung Performance in the Post-COVID-19 Condition. International Journal of Molecular Sciences, 26(5), 2046. https://doi.org/10.3390/ijms26052046
Vancouver
Fricke-Galindo I, García-Carmona S, Bautista-Becerril B, Pérez-Rubio G, Buendia-Roldan I, Chávez-Galán L, et al. Genetic Variants in Genes Related to Lung Function and Interstitial Lung Diseases Are Associated with Worse Outcomes in Severe COVID-19 and Lung Performance in the Post-COVID-19 Condition. International Journal of Molecular Sciences. 2025;26(5):2046. doi:10.3390/ijms26052046
BibTeX
@article{FrickeGalindo2025,
author = {Fricke-Galindo, Ingrid and García-Carmona, Salvador and Bautista-Becerril, Brandon and Pérez-Rubio, Gloria and Buendia-Roldan, Ivette and Chávez-Galán, Leslie and Nava-Quiroz, Karol J and Alanis-Ponce, Jesús and Reséndiz-Hernández, Juan M and Blanco-Aguilar, Esther and Erives-Sedano, Jessica I and Méndez-Velasco, Yashohara and Osuna-Espinoza, Grecia E and Salvador-Hernández, Fidel and Segura-Castañeda, Rubén and Solano-Candia, Uriel N and Falfán-Valencia, Ramcés},
title = {Genetic Variants in Genes Related to Lung Function and Interstitial Lung Diseases Are Associated with Worse Outcomes in Severe COVID-19 and Lung Performance in the Post-COVID-19 Condition},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {2046},
doi = {10.3390/ijms26052046}
}
EUVIMED